Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation

  1. Herranz-Pinto, P.
  2. Alonso-Pacheco, M.L.
  3. Feltes-Ochoa, R.
  4. Mayor-Ibarguren, A.
  5. Servera-Negre, G.
  6. Busto-Leis, J.M.
  7. Gonzalez-Fernández, M.A.
  8. Herrero-Ambrosio, A.
Journal:
Clinical Drug Investigation

ISSN: 1179-1918 1173-2563

Year of publication: 2023

Volume: 43

Issue: 7

Pages: 517-527

Type: Article

DOI: 10.1007/S40261-023-01280-9 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals